| pubmed-article:12186440 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0242485 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0031082 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0872169 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C0079809 | lld:lifeskim |
| pubmed-article:12186440 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:12186440 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:12186440 | pubmed:dateCreated | 2002-8-20 | lld:pubmed |
| pubmed-article:12186440 | pubmed:abstractText | The authors performed this study to determine the feasibility of using quantitative 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) to monitor the response of breast cancer bone metastases to therapy. | lld:pubmed |
| pubmed-article:12186440 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12186440 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12186440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12186440 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12186440 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12186440 | pubmed:issn | 1076-6332 | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:MankoffDavid... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:SchubertErin... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:DunnwaldLisa... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:GralowJulie... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:LivingstonRob... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:StaffordSteph... | lld:pubmed |
| pubmed-article:12186440 | pubmed:author | pubmed-author:RinnKristine... | lld:pubmed |
| pubmed-article:12186440 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12186440 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:12186440 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12186440 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12186440 | pubmed:pagination | 913-21 | lld:pubmed |
| pubmed-article:12186440 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:meshHeading | pubmed-meshheading:12186440... | lld:pubmed |
| pubmed-article:12186440 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12186440 | pubmed:articleTitle | Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy. | lld:pubmed |
| pubmed-article:12186440 | pubmed:affiliation | Division of Medical Oncology, University of Washington Medical Center, Seattle 98195, USA. | lld:pubmed |
| pubmed-article:12186440 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12186440 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12186440 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:12186440 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12186440 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12186440 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12186440 | lld:pubmed |
